A mild phenoxysilyl linker for self-immolative release of antibody-drug conjugates

被引:4
|
作者
Wei, Ding [1 ,2 ,3 ]
Mao, Yurong [2 ,3 ]
Wang, Huihui [2 ,3 ]
Qu, Siqi [2 ,3 ]
Chen, Jiakang [2 ]
Li, Jiusheng [1 ]
Jiang, Biao [2 ]
Chen, Hongli [2 ]
机构
[1] Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai 201210, Peoples R China
[2] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
关键词
Antibody-drug conjugates; Self-immolative release; Phenoxysilyl linker; Combretastatin A4 (CA4); DELIVERY; ACTIVATION; PAYLOADS; DESIGN;
D O I
10.1016/j.cclet.2022.108091
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Self-immolative linkers have been widely used to construct prodrugs to improve their efficacy and safety. In this study, we report the use of phenoxysilyl linker as a self-immolative unit to prepare antibody-drug conjugates (ADCs). Phenoxysily based ADC Ate-PPS-CA4 was prepared and its release was systematically investigated by mass spectrometry. Biological evaluation showed that Ate-PPS-CA4 displayed the ability to target delivery and self-immolative release the active payload CA4 on PD-L1 positive cells MDA-MB-231. As the same with its payload CA4, it could arrest the cell cycle to the G2/M phase and induced changes in cell morphology at the dose of its IC50. The development of this linker with novel drug release mechanisms will expand the methodology to construct ADCs, especially for non-internalizing ADCs by extracellular cleavage.(c) 2023 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Antibody-drug conjugates in gynecologic malignancies
    Lee, Elizabeth K.
    Liu, Joyce F.
    GYNECOLOGIC ONCOLOGY, 2019, 153 (03) : 694 - 702
  • [32] Resistance to antibody-drug conjugates: A review
    Li, Sijia
    Zhao, Xinyu
    Fu, Kai
    Zhu, Shuangli
    Pan, Can
    Yang, Chuan
    Wang, Fang
    To, Kenneth K. W.
    Fu, Liwu
    ACTA PHARMACEUTICA SINICA B, 2025, 15 (02) : 737 - 756
  • [33] Antibody-drug conjugates: Current status and future perspectives
    Gebleux, Remy
    Casi, Giulio
    PHARMACOLOGY & THERAPEUTICS, 2016, 167 : 48 - 59
  • [34] Impact of Payload Hydrophobicity on the Stability of Antibody-Drug Conjugates
    Buecheler, Jakob W.
    Winzer, Matthias
    Tonillo, Jason
    Weber, Christian
    Gieseler, Henning
    MOLECULAR PHARMACEUTICS, 2018, 15 (07) : 2656 - 2664
  • [35] Considerations for the Nonclinical Safety Evaluation of Antibody-Drug Conjugates
    Fisher, J. Edward, Jr.
    ANTIBODIES, 2021, 10 (02)
  • [36] Self-immolative base-mediated conjugate release from triazolylmethylcarbamates
    Blencowe, Christopher A.
    Thornthwaite, David W.
    Hayes, Wayne
    Russell, Andrew T.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2015, 13 (32) : 8703 - 8707
  • [37] Chemical Modification of Linkers Provides Stable Linker-Payloads for the Generation of Antibody-Drug Conjugates
    Poudel, Yam B.
    Chowdari, Naidu S.
    Cheng, Heng
    Iwuagwu, Christiana I.
    King, H. Dalton
    Kotapati, Srikanth
    Passmore, David
    Rampulla, Richard
    Mathur, Arvind
    Vite, Gregory
    Gangwar, Sanjeev
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (11): : 2190 - 2194
  • [38] Risk Evaluation of N-Nitrosamines in Drug-Linker Intermediates Used To Generate Antibody-Drug Conjugates
    Chahrour, Osama
    Bulger, Paul G.
    Dirat, Olivier
    Schrier, Kate
    Parsons, Andrew T.
    Ford, J. Gair
    Bernardoni, Frank
    Hetrick, Evan M.
    Bonaga, Llorente R.
    Cole, Kevin P.
    Miller, Joy
    Zhang, Qunying
    Jones, Michael T.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2024, 28 (08) : 3085 - 3093
  • [39] Antibody-Drug Conjugates for the Treatment of Non-Hodgkin's Lymphoma: Target and Linker-Drug Selection
    Polson, Andrew G.
    Calemine-Fenaux, Jill
    Chan, Pamela
    Chang, Wesley
    Christensen, Erin
    Clark, Suzanna
    de Sauvage, Frederic J.
    Eaton, Dan
    Elkins, Kristi
    Elliott, J. Michael
    Frantz, Gretchen
    Fuji, Reina N.
    Gray, Alane
    Harden, Kristin
    Ingle, Gladys S.
    Kljavin, Noelyn M.
    Koeppen, Hartmut
    Nelson, Christopher
    Prabhu, Saileta
    Raab, Helga
    Ross, Sarajane
    Stephan, Jean-Philippe
    Scales, Suzie J.
    Spencer, Susan D.
    Vandlen, Richard
    Wranik, Bernd
    Yu, Shang-Fan
    Zheng, Bing
    Ebens, Allen
    CANCER RESEARCH, 2009, 69 (06) : 2358 - 2364
  • [40] Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced in vivo Performance
    Evans, Nick
    Grygorash, Ruslan
    Williams, Paul
    Kyle, Andrew
    Kantner, Terrence
    Pathak, Ravindra
    Sheng, XiaoBo
    Simoes, Fabio
    Makwana, Hiteshri
    Resende, Ricardo
    de Juan, Elena
    Jenkins, Alan
    Morris, David
    Michelet, Aurelie
    Jewitt, Frances
    Rudge, Felicity
    Camper, Nicolas
    Manin, Anais
    McDowell, William
    Pabst, Martin
    Godwin, Antony
    Frigerio, Mark
    Bird, Matthew
    FRONTIERS IN PHARMACOLOGY, 2022, 13